A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024)
BackgroundThe management of long-term cardiotoxicity has become increasingly challenging despite the growing utilization of targeted therapies to enhance progression-free and overall survival rates. Although there is a proliferation of literature on the incidence and mechanisms of cardiotoxicity ind...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1593178/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849682920238743552 |
|---|---|
| author | Guoming Chen Guang Chen Huiping Zhou Qingyi Yang Yifan Shang Rui Qin Yingyue Hou Cheng Zhang Jiarui Lin Xuan Ye Ning Wang Yibin Feng |
| author_facet | Guoming Chen Guang Chen Huiping Zhou Qingyi Yang Yifan Shang Rui Qin Yingyue Hou Cheng Zhang Jiarui Lin Xuan Ye Ning Wang Yibin Feng |
| author_sort | Guoming Chen |
| collection | DOAJ |
| description | BackgroundThe management of long-term cardiotoxicity has become increasingly challenging despite the growing utilization of targeted therapies to enhance progression-free and overall survival rates. Although there is a proliferation of literature on the incidence and mechanisms of cardiotoxicity induced by targeted therapies, no comprehensive analysis of the publication landscape has addressed the unmet medical needs in this area. This study aimed to characterize global research trends, map collaborative networks, and highlight unresolved issues in cardiotoxicity management to fill the gaps in this field and inform future research.MethodThis study conducted a bibliometric analysis of articles concerning targeted therapy-induced cardiotoxicity published between 2004 and 2024 from the Web of Science (WOS) database using VOSviewer and CiteSpace. A total of 1,054 publications from 71 countries/regions and 2,058 research institutions were examined.ResultThe number of publications has shown an average annual increase of 50 articles from 2004 to 2024. Key research topics in targeted therapy cardiotoxicity encompass breast cancer, heart failure, and drug delivery. The most cited publication is a guideline titled “Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.” These results indicate a rising trend in research on tumor-targeted therapy cardiotoxicity over the past two decades. Recent research trends and future directions primarily focus on two key areas: the development of novel nanocarriers aims to enhance therapeutic efficacy while reducing cardiac toxicity, and the exploration of mechanisms underlying cardiac injury caused by targeted therapeutic drugs is crucial, along with the investigates drug interventions to counter these mechanisms or the application of alternative techniques for the prevention, alleviation, or treatment of cardiac injury.ConclusionThis study provides a comprehensive overview of targeted therapy-induced cardiotoxicity research from 2004 to 2024. By identifying key research priorities, this analysis addresses critical gaps in current knowledge. Future endeavors should prioritize translational innovations and multidisciplinary clinical frameworks to enhance therapeutic safety. |
| format | Article |
| id | doaj-art-f0ebf4fd11fb4a8eb8519e93da33dadd |
| institution | DOAJ |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-f0ebf4fd11fb4a8eb8519e93da33dadd2025-08-20T03:24:02ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-06-011210.3389/fmed.2025.15931781593178A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024)Guoming Chen0Guang Chen1Huiping Zhou2Qingyi Yang3Yifan Shang4Rui Qin5Yingyue Hou6Cheng Zhang7Jiarui Lin8Xuan Ye9Ning Wang10Yibin Feng11School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaSchool of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaFoshan Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, ChinaClinical Medical College of Acupuncture-Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, ChinaFirst Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, ChinaSchool of Information Engineering, Guizhou University of Traditional Chinese Medicine, Guiyang, ChinaSchool of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaFirst Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, ChinaFirst Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, ChinaSchool of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaSchool of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaBackgroundThe management of long-term cardiotoxicity has become increasingly challenging despite the growing utilization of targeted therapies to enhance progression-free and overall survival rates. Although there is a proliferation of literature on the incidence and mechanisms of cardiotoxicity induced by targeted therapies, no comprehensive analysis of the publication landscape has addressed the unmet medical needs in this area. This study aimed to characterize global research trends, map collaborative networks, and highlight unresolved issues in cardiotoxicity management to fill the gaps in this field and inform future research.MethodThis study conducted a bibliometric analysis of articles concerning targeted therapy-induced cardiotoxicity published between 2004 and 2024 from the Web of Science (WOS) database using VOSviewer and CiteSpace. A total of 1,054 publications from 71 countries/regions and 2,058 research institutions were examined.ResultThe number of publications has shown an average annual increase of 50 articles from 2004 to 2024. Key research topics in targeted therapy cardiotoxicity encompass breast cancer, heart failure, and drug delivery. The most cited publication is a guideline titled “Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.” These results indicate a rising trend in research on tumor-targeted therapy cardiotoxicity over the past two decades. Recent research trends and future directions primarily focus on two key areas: the development of novel nanocarriers aims to enhance therapeutic efficacy while reducing cardiac toxicity, and the exploration of mechanisms underlying cardiac injury caused by targeted therapeutic drugs is crucial, along with the investigates drug interventions to counter these mechanisms or the application of alternative techniques for the prevention, alleviation, or treatment of cardiac injury.ConclusionThis study provides a comprehensive overview of targeted therapy-induced cardiotoxicity research from 2004 to 2024. By identifying key research priorities, this analysis addresses critical gaps in current knowledge. Future endeavors should prioritize translational innovations and multidisciplinary clinical frameworks to enhance therapeutic safety.https://www.frontiersin.org/articles/10.3389/fmed.2025.1593178/fulltargeted therapycardiotoxicitybibliometricscancerVOSviewerCiteSpace |
| spellingShingle | Guoming Chen Guang Chen Huiping Zhou Qingyi Yang Yifan Shang Rui Qin Yingyue Hou Cheng Zhang Jiarui Lin Xuan Ye Ning Wang Yibin Feng A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024) Frontiers in Medicine targeted therapy cardiotoxicity bibliometrics cancer VOSviewer CiteSpace |
| title | A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024) |
| title_full | A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024) |
| title_fullStr | A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024) |
| title_full_unstemmed | A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024) |
| title_short | A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024) |
| title_sort | bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients 2004 2024 |
| topic | targeted therapy cardiotoxicity bibliometrics cancer VOSviewer CiteSpace |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1593178/full |
| work_keys_str_mv | AT guomingchen abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT guangchen abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT huipingzhou abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT qingyiyang abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT yifanshang abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT ruiqin abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT yingyuehou abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT chengzhang abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT jiaruilin abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT xuanye abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT ningwang abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT yibinfeng abibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT guomingchen bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT guangchen bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT huipingzhou bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT qingyiyang bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT yifanshang bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT ruiqin bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT yingyuehou bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT chengzhang bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT jiaruilin bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT xuanye bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT ningwang bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 AT yibinfeng bibliometricanalysisoftargetedtherapycardiotoxicityresearchincancerpatients20042024 |